The Canadian author of the prescient 1984 novel ‘The Handmaid’s Tale’ looks back on a prolific career and shares life lessons in ‘Book of Lives.’ ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

Junk bonds have a reputation of trading similar to stocks with respect to volatility. But Treasuries are considered to be the safe haven asset (for now). Thus, when HYG outperforms IEI, it's ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

A New History of the World’s Oldest Asset” by Mike Bird ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in ...

In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...